Company intelligence / Profile preview

Beaura

Dubai, Dubai, United Arab Emirates

Ownership: Private
Development stage: Other

Overview

Beaura is a Dubai-based pharmaceutical company specializing in supportive care solutions for oncology patients. The company's lead product, Encer, is a homeopathic medicine designed to manage cancer treatment-related fatigue (CTRF), a common and debilitating side effect of conventional oncological treatments. Led by Dr. Yakov Freed, Beaura is also engaged in research and development, with patent filings indicating a focus on antineoplastic preparations and biologics. The company aims to provide innovative therapies that enhance the quality of life for individuals undergoing complex medical treatments.

Therapeutic areas: Oncology
Modalities: HomeopathicBiologicProtein
Industry: Biotech

Beyond the preview

Go deeper on Beaura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beaura.

Explore the full profile